This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Respiratory Devices Market

Market Insights on Respiratory Devices covering sales outlook, demand forecast & up-to-date key trends

Respiratory Devices Market by Product (Respiratory Consumables, Nebulizers, Oxygen Concentrators, Positive Airway Pressure (PAP) Devices, Polysomnography Devices, Pulse Oximeters, Mechanical Ventilators, Spirometers), End Users & Region - Forecast to 2021-2031

Respiratory Devices Market - About the Report

[250 Pages Report]  The rising prevalence of respiratory diseases has been pushing for innovation in the manufacturing of respiratory devices. Patients suffering from asthma and chronic obstructive pulmonary diseases (COPD) have been seeking out better precision in drug delivery, which has led to an increase in adoption of respiratory devices. Favorable reimbursement policies by governments encourage manufacturing and sales of respiratory devices.

In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers insights about key factors driving demand for respiratory devices. The report tracks the global sales of Respiratory Devices in 20+ high-growth markets, along with analyzing the impact COVID-19 has had on the medical device industry in general, and respiratory devices in particular.

Customize this Report

Let us know your requirement to get
100% FREE customization

What is Future Outlook for Respiratory Devices Market in Comparison to Historical Pattern?

According to the World Health Organization (WHO), chronic obstructive pulmonary diseases (COPD) is a major health concern and is one of the leading causes of death globally. Technologically advanced medical devices and effective drugs have become key to the management of COPD and other respiratory disorders.

For instance, in 2016, the United Nations created Sustainable Development Goals (SDG) to improve living standard across the world. Similarly, the Forum of International Respiratory Societies (FIRS) was developed to address the soaring burdens of respiratory disorders. These efforts plays important role in increasing demand for respiratory devices. According to FMI’s analysis, respiratory devices sales have grown at 9.1% CAGR between 2021 and 2031.

Several new drugs were launched for the management of COPD and other respiratory diseases such as asthma over the last decade. With the number of products in pipeline increasing, the Respiratory Devices Market will have greater scope for expansion especially as the demand for respiratory devices has surged amid COVID-19 outbreak.

Respiratory Devices Market Download Report Brochure

The pandemic crisis has led to fast-track drug approval and product launch and is the most trended among pharmaceutical manufacturers. The COVID-19 has resulted in alliances between healthcare and non-healthcare industries to manufacture respiratory devices. Manufacturers are producing increased quantities of respiratory devices to meet growing demand. These developments present a positive aspect of growth. FMI expects global respiratory devices market to grow at 9.1% CAGR through 2031.

How are Combination Therapies Influencing Respiratory Devices Sales?

The use of combination therapies for the treatment of COPD and asthma has grown continuously. Patients are preferring combined therapies due to its advantages such as increased efficacy, more reliability in complex patients, and favorable reimbursement policies related to therapy. The increasing preference for combination therapies such as triple combination therapy is a key factor for respiratory devices manufacturers.

Combination therapies are considered a reliable source of treatment for patients with complex respiratory disorders. Besides this, favorable reimbursement schemes have been encouraging the usage of these therapies. 

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

How Will the Adoption of Portable Respiratory Devices Aid Growth?

Technology plays a key role in raising the bar for inhalers and nebulizers by improving the quality and increasing ease of use of these devices. This would ultimately increase patient compliance. The advantages of portable devices such as lightweight, small shape and easy to carry drives the adoption of these devices. Patients suffering from chronic respiratory diseases require continuous oxygen supply. A portable oxygen concentrator has several other benefits which make it the best choice of device. The portable oxygen concentrators can be the future oxygen delivery device for toddlers.

Combination of cell phones and respiratory devices such as spirometers, pulse oximeters, insists doctors access telemedicine services and data easily. Government initiatives for use of spirometer devices and rising prevalence of chronic diseases are expected to create demand in top regions.

Some of the leading Respiratory Devices Market players are aiming at launching portable devices. For instance, in April 01, 2019, InnAccel has launched SAANS, which has been claimed to be the world’s first infrastructure-independent, neonatal, portable (continuous positive airway pressure) CPAP system. Meanwhile, Aptar Pharma has recently launched a new portable and ready-to-use delivery solution designed for upper respiratory care, which it calls PureHale.

What is the Impact of Regulations on Respiratory Devices Sale?

According to the World Health Organization (WHO) forecast, COPD will become the third leading cause of death across the world by 2025. The rising prevalence of respiratory ailments and the increasing demand for effective treatment has been surging growth opportunities. With the implementation of favorable reimbursement policies, the Respiratory Devices Market is expected to gain remarkable growth in the new few years.

Improvements in the government healthcare system and growing focus towards advanced treatment with better accessibility will create profitable growth prospective. For instance, the Affordable Care Act is implemented to help nearly 40 Mn uninsured Americans to gain access to healthcare services.

Similarly, England provides free health services for people. The National Health Service (NHS) provides preventive medicines, primary care and hospital services to every person of the country. For instance, in 2018 radical changes were introduced in NHS that will allow social care leaders to formally devise care for individual patients, which will be increasingly made available away from hospitals. These developments aimed at making healthcare better accessible will present a conducive environment for respiratory devices sales.

Likewise, the universal healthcare system in Japan is famous for providing low-cost healthcare polices to people. As per OCED, Japan’s healthcare is focusing on improving the quality of care as well as on controlling costs. Favorable regulatory policies will further continue steady growth in sales through the forecast period.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Opportunities Abound in COPD Treatment

According to FMI, the demand for respiratory devices will be higher for the treatment of COPD. While the disease indication will continue leading, the COPD segment is anticipated to grow rapidly in the forecast year. Apart from the rising prevalence of COPD, increasing healthcare expenditure around the world will also be expected to expand the growth of the respiratory devices market.

According to the Global Burden of Disease Study report published by WHO, in 2016, about 251 million new cases of COPD are diagnosed globally. With the incidence of the disease forecast to rise, the demand for nebulizers to treat COPD is expected to surge in the next few years.

Respiratory Devices Market - Country-wise Insights

How big is the opportunity for Respiratory Devices Sales in U.S.?

FMI has projected the U.S. to remain one of the most lucrative Respiratory Devices Market throughout the forecast period. One of the key factors supporting expansion is the region’s high healthcare spending. As per CMS’ preliminary forecasts by Office of the Actuary, the total healthcare expenditure in the U.S. alone is likely to increase at 5.4% between 2019 and 2028, outpacing the country’s GDP by 4.3%.

Furthermore, the U.S. remains one of the largest markets for medical devices globally, which invariably makes it a lucrative pocket for respiratory devices manufacturers. According to SelectUSA the medical devices market in the U.S. forecasted for 40% of the global market in 2017. By 2023, it is projected to reach 203 Bn US$. As per the Centers for Medicare & Medicaid Services (CMS), retail spending for durable medical equipment in the U.S. stood at 54.4 Bn US$ in 2017. It is projected to increase in the coming years, which is indicative of remarkable scope for expansion it will offer to respiratory devices companies.

Favorable healthcare policies, coupled with high per capita healthcare spending, has created a conducive environment for the adoption of respiratory devices in the U.S. Also the presence of leading players such as ResMed Inc. and Medtronic plc., are supporting growth in the U.S. Strategies undertaken by these companies include product launches and expansion plans, which will continue aiding overall expansion in the U.S.

UK’s Medical Device Sales Need Revival

The adoption of respiratory devices is expected to rise considerably across hospitals and healthcare facilities in countries across the UK. As a result of efforts by various government organizations such as the European Academy of Allergy & Clinical Immunology to spread awareness about COPD and other respiratory diseases such as asthma, the demand for respiratory devices is believed to surge. As per FMI Europe is the second-leading market, a position it is likely to hold on to through the projected period.

According to University of Edinburgh research, in England COPD treatment costs is likely to exceed 2.5bn euro by 2030. This is indicative of increased health spending on treatment of respiratory ailments, which represents the scope for the expansion in the U.K. According to the Economic Co-operation and Development Organization of the U.K., in 2017, the country spends approximately 2,989 euro per person for health. With healthcare expenditure in the U.K. forecast to grow significantly, sales prospects are likely to get better.

Why Innovation is Key to Succeed in German Medical Device Market?

The Federal Statistical Office has reported that healthcare spending in Germany rose by 4% in 2018 from 2017. In 2018, Germany spend 11.7% of the GDP on healthcare expenditure. Moreover, healthcare spending was anticipated to increase to 407.4 billion Euros by the end of 2019, presenting a lucrative landscape for the expansion of the respiratory devices.

Also, the presence of companies such as Drägerwerk AG & Co. KGaA is supporting the expansion in Germany. The company makes affordable and effective technology possible to produce Seattle PAP, a patented innovation for the treatment of respiratory distress symptoms in babies and children. Besides this, the company has been investing significantly in expansion efforts. Growth strategies adopted by these companies are expected to aid the expansion in Germany.

Since 2009, health insurance has been made mandatory for all citizens of the country. According to NCBI, a total of 70 million people, which roughly covers 85% of the population are covered by statutory health insurance. Another 11% population of Germany is covered by substitutive private health insurance. Conducive reimbursement policies and regulatory scenario are presenting attractive growth opportunities.  

Sales in France Tied Closely to Healthcare Spending

As per the National Center for Biotechnology Information (NCBI), annually 530 Euro per COPD patient is incurred with considerable use of healthcare resources. Similarly, another survey by NCBI revealed that the prevalence of COPD was estimated to be around 1.0% to 11.1% among French adults. The high burden of respiratory disease in France is leading to increasing demand for effective treatment measures. The sale of respiratory devices is expected to surge in the country.

According to the World Bank, the healthcare expenditure in France is stood nearly at 11.25% of the GDP in 2018. This represents a decrease in healthcare spending than in 2017, the position of healthcare continues to remain in the country. Coupled with favorable government initiatives, increased cases of respiratory diseases will keep respiratory devices demand high in France.

What is Surging Demand for Respiratory Devices in China?

Growth in South Asia is anticipated to happen at an accelerated pace through forecast years. The World Health Organization has reported that in 2015 almost 3.17 million people across the world are died due to COPD and 90% of COPD deaths were recorded in low and middle-income countries, including China.

A nationwide survey conducted in China revealed that about 8.6% of adults in China are suffering from COPD in 2018. Based on results revealed in the Global Burden of Disease Study, COPD was the fourth-leading cause of death in the country in 2013. These figures are indicative of opportunities for wider penetration in China, subsequently South Asia. A rise in the prevalence of sleep disorders in Asian countries such as China is another key factor driving rapid growth in the Respiratory Devices Market.

Respiratory Devices Market - Category-wise Insights

What’s the Market Share of Positive Airway Pressure (PAP) Devices?

The positive airway pressure (PAP) devices segment will continue accounting for over half of the global share among products through the forecast period. According to FMI, the segment is expected to hold a little above 35% of the market, in terms of product type, by the end of 2031. Positive airway pressure (PAP) devices offer greater precision and straightforward usage, which are the leading causes behind the dominance of the segment. Positive Airway Pressure (PAP) devices reduce daytime sleepiness by keeping airway passages open. Also, it possibly reduces other sleep apnea-related health problems such as high blood pressure, diabetes, heart disease, and stroke.

How Much Do Hospitals Contribute towards Respiratory Devices Sales?

Driven by higher footprint of patients, hospitals have continued accounting for leading share in the Respiratory Devices Market among end users. Through the course of the forecast period, hospitals are expected to record high demand for respiratory devices. The outbreak of COVID-19 and other pandemics has been crucial at pushing growth in the segment. For instance, several COVID-19 patients are seen to experience mild to moderate respiratory illness, which makes respiratory devices crucial for administering patient care. According to FMI, hospitals as end users are likely to account for above 42% of the market by the end of 2031. 

Competitive Landscape

Leading players are focusing on strategic acquisitions to strengthen its product portfolio. For instance, Masimo Corporation has acquired TNI medical AG ("TNI") for patients suffering from respiratory insufficiency to provide innovative pulmonary care therapy in 2020. Similarly, Resmed Inc. in 2019 completed the acquisition of HB Healthcare (HBH) and Propeller Health to provide connected health solutions for people living with chronic obstructive pulmonary disease (COPD) and other respiratory conditions like asthma.

Companies operating in the respiratory devices market are focusing on strategic collaborations to address the requirements of an expanding patient pool. For instance, In June 2020, Medtronic plc entered into a partnership with Foxconn Industrial Internet to begin manufacturing Medtronic’s Puritan Bennett 560 (PB560) ventilators in the United States.

Similarly, Smith’s Medical has signed a distribution partnership with Medline Industries for distribution of the Portex acapella, a vibratory PEP therapy device to focus on the non-acute and home care channels in 2019.

There is ample focus on innovations and USFDA approval among players. Besides aiming at a competitive advantage, key players are focusing on the expansion of their global footprint as they expect approvals from regulatory authorities. For instance, In 2019, Masimo corporation got USFDA approval for Neonatal RD SET Pulse Oximetry Sensors with improved accuracy Specifications, O3 Regional Oximetry for use on neonatal and infant patients, Radius PPG, a first tetherless SET pulse oximetry sensor solution. Likewise, Masimo corporations Rad-G Pulse Oximeter got USFDA approval in 2020 to treat respiratory disorders.

Most of the companies are focusing on new product launches with advanced technology coupled with new ventilation solution that provides respiratory support to neonates, infants, paediatrics and adults. For instance, In 2019 ResMed Inc. launched an automated ResMed ReSupply solution to increase long-term therapy adherence and improve the satisfaction of patients suffering from sleep apnea disorders.

Some of the leading companies operating in the Respiratory Devices Market? are:

  • Massimo Corporation
  • Teleflex Incorporated
  • Fisher & Paykel Healthcare Limited
  • ResMed Inc.
  • Hamilton Medical AG
  • Medtronic plc.
  • Koninklijke Philips N.V.
  • Smith’s Medical
  • General Electric Healthcare Limited
  • Drägerwerk AG & Co. KGaA
  • Inogen Inc.

*The list is not exhaustive, and only for representational purposes. Full competitive intelligence with SWOT analysis available in the report.

Scope of the Report

Attribute

Details

Respiratory Devices Market Forecast Period

2021-2031

Respiratory Devices Market Historical Data Available for

2016-2020

Respiratory Devices Market Analysis

USD Million for value and Units for Volume

Key Regions Covered

North America, Latin America, Europe, East Asia, South Asia, Oceania Middle East & Africa

Respiratory Devices Market Key Countries Covered

US, Canada, Germany, U.K., France, Italy, Spain, Poland, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Vietnam, Indonesia, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, South Africa

Respiratory Devices Market Key Segments Covered

Product Type, End Users, and Region

Key Companies Profiled

  • Massimo Corporation
  • Teleflex Incorporated
  • Fisher & Paykel Healthcare Limited
  • ResMed Inc.
  • Hamilton Medical AG
  • Medtronic plc.
  • Koninklijke Philips N.V.
  • Smith’s Medical
  • General Electric Healthcare Limited
  • Drägerwerk AG & Co. KGaA
  • Inogen Inc.

Report Coverage

Market Forecast, brand share analysis, competition intelligence, DROT analysis, Market Dynamics and Challenges, Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Respiratory Devices Market - Key Segments

Product

  • Respiratory Consumables
    • Respiratory Mask
    • Nasal Cannulas
    • Oxygen Tubing Sets
    • Breathing Filters
  • Nebulizers
    • Compressed Jet Nebulizers
    • Ultrasonic Nebulizers
  • Oxygen Concentrators
    • Home Oxygen Concentrators
    • Portable Oxygen
    • Concentrators`
  • Positive Airway Pressure (PAP) Devices
  • Polysomnography Devices
    • Ambulatory PSG Devices
    • Clinical PSG Devices
  • Pulse Oximeters
  • Mechanical Ventilators
  • Spirometers

End Users

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Long Term Care Centers
  • Others

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • The Middle East and Africa (MEA)
  • Oceania

Frequently Asked Questions

The U.S. currently leads the global market for respiratory devices. Sales in the U.S. is expected to account for the lion’s share of the North America market through the course of the report’s forecast period.

Positive Airway Pressure (PAP) Devices are highly sought-after in every market. The demand for Positive Airway Pressure (PAP) Devices is expected to remain high shortly, especially due to ease of usage and precision in drug delivery.

Some of the leading companies offering respiratory devices are Massimo Corporation, Teleflex Incorporated, Fisher & Paykel Healthcare Limited, ResMed Inc., Hamilton Medical AG, Medtronic plc, among others.

The hospital's segment is leading among the end-users. Hospitals provide respiratory care services to patients through various departments, such as pulmonary diagnostic laboratories, intensive care units, emergency rooms, and, outpatient departments, among others.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting The Market

    3.2. Product Development Trends 

4. Market Background

    4.1. Macro-Economic Factors

        4.1.1. Global GDP Growth Outlook

        4.1.2. Global Healthcare Expenditure Outlook

        4.1.3. Growth of Healthcare Sector in Emerging Nations

    4.2. Forecast Factors - Relevance & Impact

        4.2.1. Global Increase in Healthcare Expenditure

        4.2.2. Corporate Investments are Helping Advance R&D

        4.2.3. Changing Regulatory Dynamics 

        4.2.4. Cost Impact

        4.2.5. Regulatory Scenario

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunity Analysis

5. Key Success Factors

    5.1. Product Adoption / Usage Analysis

    5.2. Product USPs/ Features

    5.3. Production Analysis by Region

    5.4. Trade Analysis

    5.5. Regulatory Scenario

    5.6. Strategic Promotional Strategies by Manufacturer 

6. COVID19 Crisis Impact Analysis

    6.1. COVID19 Crisis Impact Analysis

        6.1.1. Current COVID19 Statistics and Probable Future Impact

        6.1.2. Current GDP Projection and Probable Impact

        6.1.3. Current Economic Projection as compared to 2008 Economic analysis

        6.1.4. COVID19 and Impact Analysis

    6.2. Respiratory Devices Market Revenue Impact Analysis

        6.2.1. Historical (pre-COVID), Current (during-COVID), Future (post-COVID)

            6.2.1.1. By Product

            6.2.1.2. By End User

            6.2.1.3. By Region

        6.2.2. 2020 Market Scenario

        6.2.3. Quarter by Quarter Forecast

        6.2.4. Projected Recovery Year

    6.3. Impact on Trends Analysis 

    6.4. Recovery Scenario – Short term, Midterm and Long Term Impact

7. Global Respiratory Devices Market Demand (in Value or Size in US$ Mn) Analysis 2016-2020 and Forecast, 2021–2031

    7.1. Historical Market Value (US$ Mn) Analysis, 2016-2020

    7.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Respiratory Devices Market Analysis 2016-2020 and Forecast 2021-2031, By Product Type

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2016 - 2020

    8.3. Current and Future Market Size (US$ Mn) Analysis  By Product Type, 2016 - 2020

        8.3.1. Respiratory Consumables

            8.3.1.1. Respiratory Mask

            8.3.1.2. Nasal Cannulas

            8.3.1.3. Oxygen Tubing Sets

            8.3.1.4. Breathing Filters

        8.3.2. Nebulizers

            8.3.2.1. Compressed Jet Nebulizers

            8.3.2.2. Ultrasonic Nebulizers

        8.3.3. Oxygen Concentrators

            8.3.3.1. Home Oxygen Concentrators

            8.3.3.2. Portable Oxygen

            8.3.3.3. Concentrators`

        8.3.4. Positive Airway Pressure (PAP) Devices

        8.3.5. Polysomnography Devices

            8.3.5.1. Ambulatory PSG Devices

            8.3.5.2. Clinical PSG Devices 

        8.3.6. Pulse Oximeters

        8.3.7. Mechanical Ventilators

            8.3.7.1. Spirometers

    8.4. Market Attractiveness Analysis By Product Type

9. Global Respiratory Devices Market Analysis 2016-2020 and Forecast 2021-2031, By End User

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By End User, 2016 - 2020

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2021 – 2031

        9.3.1. Hospitals

        9.3.2. Ambulatory Surgical Centers

        9.3.3. Clinics

        9.3.4. Long Term Care Centers 

        9.3.5. Others 

    9.4. Market Attractiveness Analysis By End User

10. Global Respiratory Devices Market Analysis 2016-2020 and Forecast 2021-2031, by Region

    10.1. Introduction

    10.2. Historical Market Size (US$ Mn) Analysis By Region, 2016 - 2020

    10.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2021 – 2031

        10.3.1. North America

        10.3.2. Latin America

        10.3.3. Europe

        10.3.4. East Asia

        10.3.5. South Asia

        10.3.6. Oceania

        10.3.7. Middle East and Africa (MEA)

    10.4. Market Attractiveness Analysis By Region

11. North America Respiratory Devices Market Analysis 2016-2020 and Forecast 2021-2031

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016 - 2020

    11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021 – 2031

        11.3.1. By Country

            11.3.1.1. U.S.

            11.3.1.2. Canada

        11.3.2. By Product Type

        11.3.3. By End User

    11.4. Market Attractiveness Analysis

    11.5. Key Market Participants - Intensity Mapping

    11.6. Drivers and Restraints - Impact Analysis

12. Latin America Respiratory Devices Market Analysis 2016-2020 and Forecast 2021-2031

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016 - 2020

    12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021 – 2031

        12.3.1. By Country

            12.3.1.1. Brazil

            12.3.1.2. Mexico

            12.3.1.3. Argentina

            12.3.1.4. Rest of Latin America

        12.3.2. By Product Type

        12.3.3. By End User

    12.4. Market Attractiveness Analysis

    12.5. Key Market Participants - Intensity Mapping

    12.6. Drivers and Restraints - Impact Analysis

13. Europe Respiratory Devices Market Analysis 2016-2020 and Forecast 2021-2031

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016 - 2020

    13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021 – 2031

        13.3.1. By Country

            13.3.1.1. Germany

            13.3.1.2. Italy

            13.3.1.3. France

            13.3.1.4. U.K.

            13.3.1.5. Spain

            13.3.1.6. BENELUX

            13.3.1.7. Russia

            13.3.1.8. Rest of Europe

        13.3.2. By Product Type

        13.3.3. By End User

    13.4. Market Attractiveness Analysis

    13.5. Key Market Participants - Intensity Mapping

    13.6. Drivers and Restraints - Impact Analysis

14. South Asia Respiratory Devices Market Analysis 2016-2020 and Forecast 2021-2031

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016 - 2020

    14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021 – 2031

        14.3.1. By Country

            14.3.1.1. India

            14.3.1.2. Thailand

            14.3.1.3. Indonesia

            14.3.1.4. Malaysia

            14.3.1.5. Rest of South Asia

        14.3.2. By Product Type

        14.3.3. By End User

    14.4. Market Attractiveness Analysis

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

15. East Asia Respiratory Devices Market Analysis 2016-2020 and Forecast 2021-2031

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016 - 2020

    15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021 – 2031

        15.3.1. By Country

            15.3.1.1. China

            15.3.1.2. Japan

            15.3.1.3. South Korea

        15.3.2. By Product Type

        15.3.3. By End User

    15.4. Market Attractiveness Analysis

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

16. Oceania Respiratory Devices Market Analysis 2016-2020 and Forecast 2021-2031

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016 - 2020

    16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021 – 2031

        16.3.1. By Country

            16.3.1.1. Australia

            16.3.1.2. New Zealand

        16.3.2. By Product Type

        16.3.3. By Application

        16.3.4. By Injector

        16.3.5. By End User

    16.4. Market Attractiveness Analysis

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

17. Middle East and Africa Respiratory Devices Market Analysis 2016-2020 and Forecast 2021-2031

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016 - 2020

    17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021 – 2031

        17.3.1. By Country

            17.3.1.1. GCC Countries

            17.3.1.2. South Africa

            17.3.1.3. Rest of Middle East and Africa

        17.3.2. By Product Type

        17.3.3. By End User

    17.4. Market Attractiveness Analysis

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

18. Key and Emerging Countries Respiratory Devices Market Analysis 2016-2020 and Forecast 2021-2031

    18.1. Introduction

        18.1.1. Market Value Proportion Analysis, By Key Countries

        18.1.2. Global Vs. Country Growth Comparison

    18.2. U.S. Respiratory Devices Market Analysis

        18.2.1. By Product Type

        18.2.2. By End User

    18.3. Canada Respiratory Devices Market Analysis

        18.3.1. By Product Type

        18.3.2. By End User

    18.4. Brazil Respiratory Devices Market Analysis

        18.4.1. By Product Type

        18.4.2. By End User

    18.5. U.K. Respiratory Devices Market Analysis

        18.5.1. By Product Type

        18.5.2. By End User

    18.6. Germany Respiratory Devices Market Analysis

        18.6.1. By Product Type

        18.6.2. By End User

    18.7. France Respiratory Devices Market Analysis

        18.7.1. By Product Type

        18.7.2. By End User

    18.8. Italy Respiratory Devices Market Analysis

        18.8.1. By Product Type

        18.8.2. By End User

    18.9. Spain Respiratory Devices Market Analysis

        18.9.1. By Product Type

        18.9.2. By End User

    18.10. Russia Respiratory Devices Market Analysis

        18.10.1. By Product Type

        18.10.2. By End User

    18.11. China Respiratory Devices Market Analysis

        18.11.1. By Product Type

        18.11.2. By End User

    18.12. Japan Respiratory Devices Market Analysis

        18.12.1. By Product Type

        18.12.2. By End User

    18.13. South Korea Respiratory Devices Market Analysis

        18.13.1. By Product Type

        18.13.2. By End User

    18.14. India Respiratory Devices Market Analysis

        18.14.1. By Product Type

        18.14.2. By End User

    18.15. Australia Respiratory Devices Market Analysis

        18.15.1. By Product Type

        18.15.2. By End User

    18.16. South Africa Respiratory Devices Market Analysis

        18.16.1. By Product Type

        18.16.2. By End User

19. Market Structure Analysis

    19.1. Market Analysis by Tier of Companies 

    19.2. Market Concentration

    19.3. Market Share Analysis of Top Players

    19.4. Market Presence Analysis

        19.4.1. By Regional Footprint of Players

        19.4.2. Product Footprint by Players

        19.4.3. Channel Footprint by Players

20. Competition Analysis

    20.1. Competition Dashboard

    20.2. Competition Benchmarking

    20.3. Competition Deep Dive (Tentative List)

        20.3.1. Massimo Corporation 

            20.3.1.1. Overview

            20.3.1.2. Product Portfolio

            20.3.1.3. Key Financial

            20.3.1.4. Sales Footprint

            20.3.1.5. Analyst commentary

        20.3.2. Teleflex Incorporated

            20.3.2.1. Overview

            20.3.2.2. Product Portfolio

            20.3.2.3. Key Financial

            20.3.2.4. Sales Footprint

            20.3.2.5. Analyst commentary

        20.3.3. Fisher & Paykel Healthcare Limited

            20.3.3.1. Overview

            20.3.3.2. Product Portfolio

            20.3.3.3. Key Financial

            20.3.3.4. Sales Footprint

            20.3.3.5. Analyst commentary

        20.3.4. ResMed Inc.

            20.3.4.1. Overview

            20.3.4.2. Product Portfolio

            20.3.4.3. Key Financial

            20.3.4.4. Sales Footprint

            20.3.4.5. Analyst commentary

        20.3.5. Hamilton Medical AG

            20.3.5.1. Overview

            20.3.5.2. Product Portfolio

            20.3.5.3. Key Financial

            20.3.5.4. Sales Footprint

            20.3.5.5. Analyst commentary

        20.3.6. Medtronic plc.

            20.3.6.1. Overview

            20.3.6.2. Product Portfolio

            20.3.6.3. Key Financial

            20.3.6.4. Sales Footprint

            20.3.6.5. Analyst commentary

        20.3.7. Koninklijke Philips N.V.

            20.3.7.1. Overview

            20.3.7.2. Product Portfolio

            20.3.7.3. Key Financial

            20.3.7.4. Sales Footprint

            20.3.7.5. Analyst commentary

        20.3.8. Smith’s Medical

            20.3.8.1. Overview

            20.3.8.2. Product Portfolio

            20.3.8.3. Key Financial

            20.3.8.4. Sales Footprint

            20.3.8.5. Analyst commentary

        20.3.9. General Electric Healthcare Limited

            20.3.9.1. Overview

            20.3.9.2. Product Portfolio

            20.3.9.3. Key Financial

            20.3.9.4. Sales Footprint

            20.3.9.5. Analyst commentary

        20.3.10. Drägerwerk AG & Co. KGaA

            20.3.10.1. Overview

            20.3.10.2. Product Portfolio

            20.3.10.3. Key Financial

            20.3.10.4. Sales Footprint

            20.3.10.5. Analyst commentary

        20.3.11. Inogen Inc.

            20.3.11.1. Overview

            20.3.11.2. Product Portfolio

            20.3.11.3. Key Financial

            20.3.11.4. Sales Footprint

            20.3.11.5. Analyst commentary

21. Assumptions and Acronyms Used

22. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Respiratory Devices Market Size Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Product Type

Table 03: Global Respiratory Devices Market Size Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By End User

Table 04: Global Respiratory Devices Market Size Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Region

Table 05: North America Respiratory Devices Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country

Table 06: North America Respiratory Devices Market Size Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Product Type

Table 08: North America Respiratory Devices Market Size Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By End User

Table 09: Latin America Respiratory Devices Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country

Table 10: Latin America Respiratory Devices Market Size Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Product Type

Table 12: Latin America Respiratory Devices Market Size Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By End User

Table 13: Europe Respiratory Devices Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country

Table 14: Europe Respiratory Devices Market Size Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Product Type

Table 16: Europe Respiratory Devices Market Size Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By End User

Table 17: South Asia Respiratory Devices Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country

Table 18: South Asia Respiratory Devices Market Size Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Product Type

Table 20: South Asia Respiratory Devices Market Size Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By End User

Table 21: East Asia Respiratory Devices Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country

Table 22: East Asia Respiratory Devices Market Size Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Product Type

Table 24: East Asia Respiratory Devices Market Size Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By End User

Table 25: Oceania Respiratory Devices Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country

Table 26: Oceania Respiratory Devices Market Size Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Product Type

Table 28: Oceania Respiratory Devices Market Size Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By End User

Table 29: MEA Respiratory Devices Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country

Table 30: MEA Respiratory Devices Market Size Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Product Type

Table 32: MEA Respiratory Devices Market Size Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By End User

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Respiratory Devices Market Value Analysis and Forecast, 2021–2031 (US$ Mn)

Figure 02: Global Respiratory Devices Market Value Analysis (US$ Mn), 2016-2020

Figure 03: Global Respiratory Devices Market Size (US$ Mn) & Y-o-Y Growth (%) Analysis, 2021–2031

Figure 04: Global Respiratory Devices Market Absolute $ Opportunity, 2021 - 2031

Figure 05: Global Respiratory Devices Market Share Analysis (%) By Product Type, 2021 & 2031

Figure 06: Global Respiratory Devices Market Y-o-Y Growth (%) By Product Type, 2021 - 2031

Figure 07: Global Respiratory Devices Market Attractiveness Analysis By Product Type, 2021–2031

Figure 08: Global Respiratory Devices Market Share Analysis (%) By End User, 2021 & 2031

Figure 09: Global Respiratory Devices Market Y-o-Y Growth (%) By End User, 2021 - 2031

Figure 10: Global Respiratory Devices Market Attractiveness Analysis By End User, 2021–2031

Figure 11: Global Respiratory Devices Market Share Analysis (%) By Region, 2021 & 2031

Figure 12: Global Respiratory Devices Market Y-o-Y Growth (%) By Region, 2021 - 2031

Figure 13: Global Respiratory Devices Market Attractiveness Analysis By Region, 2021–2031

Figure 14: North America Respiratory Devices Market Value Share, By Product Type, 2021 (E)

Figure 15: North America Respiratory Devices Market Value Share, By End User, 2021 (E)

Figure 16: North America Respiratory Devices Market Value Share, By Country, 2021 (E)

Figure 17: North America Respiratory Devices Market Value Analysis (US$ Mn), 2016-2020

Figure 18: North America Respiratory Devices Market Value Forecast (US$ Mn), 2021-2031

Figure 19: North America Respiratory Devices Market Attractiveness Analysis by Country, 2021-2031

Figure 20: North America Respiratory Devices Market Attractiveness Analysis By Product Type, 2021-2031

Figure 21: North America Respiratory Devices Market Attractiveness Analysis by End User, 2021-2031

Figure 22: Latin America Respiratory Devices Market Value Share, By Product Type, 2021 (E)

Figure 23: Latin America Respiratory Devices Market Value Share, By End User, 2021 (E)

Figure 24: Latin America Respiratory Devices Market Value Share, By Country, 2021 (E)

Figure 25: Latin America Respiratory Devices Market Value Analysis (US$ Mn), 2016-2020

Figure 26: Latin America Respiratory Devices Market Value Forecast (US$ Mn), 2021-2031

Figure 27: Latin America Respiratory Devices Market Attractiveness Analysis by Country, 2021-2031

Figure 28: Latin America Respiratory Devices Market Attractiveness Analysis By Product Type, 2021-2031

Figure 29: Latin America Respiratory Devices Market Attractiveness Analysis by End User, 2021-2031

Figure 30: Europe Respiratory Devices Market Value Share, By Product Type, 2021 (E)

Figure 31: Europe Respiratory Devices Market Value Share, By End User, 2021 (E)

Figure 32: Europe Respiratory Devices Market Value Share, By Country, 2021 (E)

Figure 33: Europe Respiratory Devices Market Value Analysis (US$ Mn), 2016-2020

Figure 34: Europe Respiratory Devices Market Value Forecast (US$ Mn), 2021-2031

Figure 35: Europe Respiratory Devices Market Attractiveness Analysis by Country, 2021-2031

Figure 36: Europe Respiratory Devices Market Attractiveness Analysis By Product Type, 2021-2031

Figure 37: Europe Respiratory Devices Market Attractiveness Analysis by End User, 2021-2031

Figure 38: South Asia Respiratory Devices Market Value Share, By Product Type, 2021 (E)

Figure 39: South Asia Respiratory Devices Market Value Share, By End User, 2021 (E)

Figure 40: South Asia Respiratory Devices Market Value Share, By Country, 2021 (E)

Figure 41: South Asia Respiratory Devices Market Value Analysis (US$ Mn), 2016-2020

Figure 42: South Asia Respiratory Devices Market Value Forecast (US$ Mn), 2021-2031

Figure 43: South Asia Respiratory Devices Market Attractiveness Analysis by Country, 2021-2031

Figure 44: South Asia Respiratory Devices Market Attractiveness Analysis By Product Type, 2021-2031

Figure 45: South Asia Respiratory Devices Market Attractiveness Analysis by End User, 2021-2031

Figure 46: East Asia Respiratory Devices Market Value Share, By Product Type, 2021 (E)

Figure 47: East Asia Respiratory Devices Market Value Share, By End User, 2021 (E)

Figure 48: East Asia Respiratory Devices Market Value Share, By Country, 2021 (E)

Figure 49: East Asia Respiratory Devices Market Value Analysis (US$ Mn), 2016-2020

Figure 50: East Asia Respiratory Devices Market Value Forecast (US$ Mn), 2021-2031

Figure 51: East Asia Respiratory Devices Market Attractiveness Analysis by Country, 2021-2031

Figure 52: East Asia Respiratory Devices Market Attractiveness Analysis By Product Type, 2021-2031

Figure 53: East Asia Respiratory Devices Market Attractiveness Analysis by End User, 2021-2031

Figure 54: Oceania Respiratory Devices Market Value Share, By Product Type, 2021 (E)

Figure 55: Oceania Respiratory Devices Market Value Share, By End User, 2021 (E)

Figure 56: Oceania Respiratory Devices Market Value Share, By Country, 2021 (E)

Figure 57: Oceania Respiratory Devices Market Value Analysis (US$ Mn), 2016-2020

Figure 58: Oceania Respiratory Devices Market Value Forecast (US$ Mn), 2021-2031

Figure 59: Oceania Respiratory Devices Market Attractiveness Analysis by Country, 2021-2031

Figure 60: Oceania Respiratory Devices Market Attractiveness Analysis By Product Type, 2021-2031

Figure 61: Oceania Respiratory Devices Market Attractiveness Analysis by End User, 2021-2031

Figure 62: MEA Respiratory Devices Market Value Share, By Product Type, 2021 (E)

Figure 63: MEA Respiratory Devices Market Value Share, By End User, 2021 (E)

Figure 64: MEA Respiratory Devices Market Value Share, By Country, 2021 (E)

Figure 65: MEA Respiratory Devices Market Value Analysis (US$ Mn), 2016-2020

Figure 66: MEA Respiratory Devices Market Value Forecast (US$ Mn), 2021-2031

Figure 67: MEA Respiratory Devices Market Attractiveness Analysis by Country, 2021-2031

Figure 68: MEA Respiratory Devices Market Attractiveness Analysis By Product Type, 2021-2031

Figure 69: MEA Respiratory Devices Market Attractiveness Analysis by End User, 2021-2031

Figure 70: U.S. Market Value Proportion Analysis

Figure 71: U.S. Respiratory Devices Market Share Analysis (%) By Product Type, 2020 (A)

Figure 72: U.S. Respiratory Devices Market Share Analysis (%) By End User, 2020 (A)

Figure 73: U.S. Respiratory Devices Market Value Analysis (US$ Mn), 2020 & 2031

Figure 74: Canada Market Value Proportion Analysis

Figure 75: Canada Respiratory Devices Market Share Analysis (%) By Product Type, 2020 (A)

Figure 76: Canada Respiratory Devices Market Share Analysis (%) By End User, 2020 (A)

Figure 77: Canada Respiratory Devices Market Value Analysis (US$ Mn), 2020 & 2031

Figure 78: Brazil Market Value Proportion Analysis

Figure 79: Brazil Respiratory Devices Market Share Analysis (%) By Product Type, 2020 (A)

Figure 80: Brazil Respiratory Devices Market Share Analysis (%) By End User, 2020 (A)

Figure 81: Brazil Respiratory Devices Market Value Analysis (US$ Mn), 2020 & 2031

Figure 82: Mexico Market Value Proportion Analysis

Figure 83: Mexico Respiratory Devices Market Share Analysis (%) By Product Type, 2020 (A)

Figure 84: Mexico Respiratory Devices Market Share Analysis (%) By End User, 2020 (A)

Figure 85: Mexico Respiratory Devices Market Value Analysis (US$ Mn), 2020 & 2031

Figure 86: Argentina Market Value Proportion Analysis

Figure 87: Argentina Respiratory Devices Market Share Analysis (%) By Product Type, 2020 (A)

Figure 88: Argentina Respiratory Devices Market Share Analysis (%) By End User, 2020 (A)

Figure 89: Argentina Respiratory Devices Market Value Analysis (US$ Mn), 2020 & 2031

Figure 90: U.K. Market Value Proportion Analysis

Figure 91: U.K. Respiratory Devices Market Share Analysis (%) By Product Type, 2020 (A)

Figure 92: U.K. Respiratory Devices Market Share Analysis (%) By End User, 2020 (A)

Figure 93: U.K. Respiratory Devices Market Value Analysis (US$ Mn), 2020 & 2031

Figure 94: Germany Market Value Proportion Analysis

Figure 95: Germany Respiratory Devices Market Share Analysis (%) By Product Type, 2020 (A)

Figure 96: Germany Respiratory Devices Market Share Analysis (%) By End User, 2020 (A)

Figure 97: Germany Respiratory Devices Market Value Analysis (US$ Mn), 2020 & 2031

Figure 98: Italy Market Value Proportion Analysis

Figure 99: Italy Respiratory Devices Market Share Analysis (%) By Product Type, 2020 (A)

Figure 100: Italy Respiratory Devices Market Share Analysis (%) By End User, 2020 (A)

Figure 101: Italy Respiratory Devices Market Value Analysis (US$ Mn), 2020 & 2031

Figure 102: France Market Value Proportion Analysis

Figure 103: France Respiratory Devices Market Share Analysis (%) By Product Type, 2020 (A)

Figure 104: France Respiratory Devices Market Share Analysis (%) By End User, 2020 (A)

Figure 105: France Respiratory Devices Market Value Analysis (US$ Mn), 2020 & 2031

Figure 106: Spain Market Value Proportion Analysis

Figure 107: Spain Respiratory Devices Market Share Analysis (%) By Product Type, 2020 (A)

Figure 108: Spain Respiratory Devices Market Share Analysis (%) By End User, 2020 (A)

Figure 109: Spain Respiratory Devices Market Value Analysis (US$ Mn), 2020 & 2031

Figure 110: Russia Market Value Proportion Analysis

Figure 111: Russia Respiratory Devices Market Share Analysis (%) By Product Type, 2020 (A)

Figure 112: Russia Respiratory Devices Market Share Analysis (%) By End User, 2020 (A)

Figure 113: Russia Respiratory Devices Market Value Analysis (US$ Mn), 2020 & 2031

Figure 114: BENELUX Market Value Proportion Analysis

Figure 115: BENELUX Respiratory Devices Market Share Analysis (%) By Product Type, 2020 (A)

Figure 116: BENELUX Respiratory Devices Market Share Analysis (%) By End User, 2020 (A)

Figure 117: BENELUX Respiratory Devices Market Value Analysis (US$ Mn), 2020 & 2031

Figure 118: India Market Value Proportion Analysis

Figure 119: India Respiratory Devices Market Share Analysis (%) By Product Type, 2020 A)

Figure 120 India Respiratory Devices Market Share Analysis (%) By End User, 2020 (A)

Figure 121: India Respiratory Devices Market Value Analysis (US$ Mn), 2020 & 2031

Figure 122: Thailand Market Value Proportion Analysis

Figure 123: Thailand Respiratory Devices Market Share Analysis (%) By Product Type, 2020 (A)

Figure 124: Thailand Respiratory Devices Market Share Analysis (%) By End User, 2020 (A)

Figure 125: Thailand Respiratory Devices Market Value Analysis (US$ Mn), 2020 & 2031

Figure 126: Malaysia Market Value Proportion Analysis

Figure 127: Malaysia Respiratory Devices Market Share Analysis (%) By Product Type, 2020 (A)

Figure 128: Malaysia Respiratory Devices Market Share Analysis (%) By End User, 2020 (A)

Figure 129: Malaysia Respiratory Devices Market Value Analysis (US$ Mn), 2020 & 2031

Figure 130: Indonesia Market Value Proportion Analysis

Figure 131: Indonesia Respiratory Devices Market Share Analysis (%) By Product Type, 2020(A)

Figure 132: Indonesia Respiratory Devices Market Share Analysis (%) By End User, 2020(A)

Figure 133: Indonesia Respiratory Devices Market Value Analysis (US$ Mn), 2020 & 2031

Figure 134: China Market Value Proportion Analysis

Figure 135: China Respiratory Devices Market Share Analysis (%) By Product Type, 2020 (A)

Figure 136: China Respiratory Devices Market Share Analysis (%) By End User, 2020 (A)

Figure 137: China Respiratory Devices Market Value Analysis (US$ Mn), 2020 & 2031

Figure 138: Japan Market Value Proportion Analysis

Figure 139: Japan Respiratory Devices Market Share Analysis (%) By Product Type, 2020 (A)

Figure 140: Japan Respiratory Devices Market Share Analysis (%) By End User, 2020 (A)

Figure 141: Japan Respiratory Devices Market Value Analysis (US$ Mn), 2020 & 2031

Figure 142: South Korea Market Value Proportion Analysis

Figure 143: South Korea Respiratory Devices Market Share Analysis (%) By Product Type, 2020 (A)

Figure 144: South Korea Respiratory Devices Market Share Analysis (%) By End User, 2020 (A)

Figure 145: South Korea Respiratory Devices Market Value Analysis (US$ Mn), 2020 & 2031

Figure 146: Australia Market Value Proportion Analysis

Figure 147: Australia Respiratory Devices Market Share Analysis (%) By Product Type, 2020 (A)

Figure 148: Australia Respiratory Devices Market Share Analysis (%) By End User, 2020 (A)

Figure 149: Australia Respiratory Devices Market Value Analysis (US$ Mn), 2020 & 2031

Figure 150: New Zealand Market Value Proportion Analysis

Figure 151: New Zealand Respiratory Devices Market Share Analysis (%) By Product Type, 2020 (A)

Figure 152: New Zealand Respiratory Devices Market Share Analysis (%) By End User, 2020 (A)

Figure 153: New Zealand Respiratory Devices Market Value Analysis (US$ Mn), 2020 & 2031

Figure 154: Turkey Market Value Proportion Analysis

Figure 155: Turkey Respiratory Devices Market Share Analysis (%) By Product Type, 2020 (A)

Figure 156: Turkey Respiratory Devices Market Share Analysis (%) By End User, 2020 (A)

Figure 157: Turkey Respiratory Devices Market Value Analysis (US$ Mn), 2020 & 2031

Figure 158: GCC Market Value Proportion Analysis

Figure 159: GCC Respiratory Devices Market Share Analysis (%) By Product Type, 2020 (A)

Figure 160: GCC Respiratory Devices Market Share Analysis (%) By End User, 2020 (A)

Figure 161: GCC Respiratory Devices Market Value Analysis (US$ Mn), 2020 & 2031

Figure 162: South Africa Market Value Proportion Analysis

Figure 163: South Africa Respiratory Devices Market Share Analysis (%) By Product Type, 2020 (A)

Figure 164: South Africa Respiratory Devices Market Share Analysis (%) By End User, 2020 (A)

Figure 165: South Africa Respiratory Devices Market Value Analysis (US$ Mn), 2020 & 2031

Figure 166: North Africa Market Value Proportion Analysis

Figure 167: North Africa Respiratory Devices Market Share Analysis (%) By Product Type, 2020 (A)

Figure 168: North Africa Respiratory Devices Market Share Analysis (%) By End User, 2020 (A)

Figure 169: North Africa Respiratory Devices Market Value Analysis (US$ Mn), 2020 & 2031

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Respiratory Devices Market